ITRM910673A1 - Composizioni farmaceutiche contenenti derivati di furano e procedimento per prepararle. - Google Patents

Composizioni farmaceutiche contenenti derivati di furano e procedimento per prepararle.

Info

Publication number
ITRM910673A1
ITRM910673A1 IT000673A ITRM910673A ITRM910673A1 IT RM910673 A1 ITRM910673 A1 IT RM910673A1 IT 000673 A IT000673 A IT 000673A IT RM910673 A ITRM910673 A IT RM910673A IT RM910673 A1 ITRM910673 A1 IT RM910673A1
Authority
IT
Italy
Prior art keywords
prepare
procedure
pharmaceutical compositions
compositions containing
furan derivatives
Prior art date
Application number
IT000673A
Other languages
English (en)
Inventor
Stephen John Douglas
Colin Roy Heppenstall
Norman Richard Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ITRM910673A0 publication Critical patent/ITRM910673A0/it
Publication of ITRM910673A1 publication Critical patent/ITRM910673A1/it
Application granted granted Critical
Publication of IT1249696B publication Critical patent/IT1249696B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)
ITRM910673A 1990-09-11 1991-09-10 Composizioni farmaceutiche contenenti derivati di furano e procedimento per prepararle. IT1249696B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (3)

Publication Number Publication Date
ITRM910673A0 ITRM910673A0 (it) 1991-09-10
ITRM910673A1 true ITRM910673A1 (it) 1993-03-10
IT1249696B IT1249696B (it) 1995-03-09

Family

ID=47884627

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910673A IT1249696B (it) 1990-09-11 1991-09-10 Composizioni farmaceutiche contenenti derivati di furano e procedimento per prepararle.

Country Status (33)

Country Link
US (1) US5456925A (it)
EP (1) EP0558779B1 (it)
JP (1) JPH0692849A (it)
KR (1) KR100196308B1 (it)
AT (2) AT405134B (it)
AU (2) AU640816B2 (it)
BE (1) BE1005115A5 (it)
BG (1) BG61931B1 (it)
CA (1) CA2050970C (it)
CH (1) CH683068A5 (it)
CY (1) CY1988A (it)
DE (2) DE4130061A1 (it)
DK (1) DK159191A (it)
ES (1) ES2072647T3 (it)
FI (1) FI944047A (it)
FR (1) FR2666508B1 (it)
GB (2) GB9019875D0 (it)
HK (1) HK60894A (it)
HU (1) HU211846A9 (it)
IE (1) IE65049B1 (it)
IL (1) IL99428A (it)
IT (1) IT1249696B (it)
MX (1) MX9101009A (it)
NL (1) NL194907C (it)
NO (1) NO179694C (it)
NZ (1) NZ239731A (it)
OA (1) OA10093A (it)
RO (1) RO112084B1 (it)
RU (1) RU2108097C1 (it)
SE (1) SE509694C2 (it)
SK (1) SK279591B6 (it)
WO (1) WO1993017679A1 (it)
ZA (1) ZA917176B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
US6117412A (en) * 1995-01-26 2000-09-12 Nycomed Imaging As Non-cluster type bismuth compounds
WO2000010562A1 (fr) * 1998-08-18 2000-03-02 Leonidov Nikolai B Forme physiquement stable et amorphe aux rayons x de ranitidine d'hydrochlorure ayant une action anti-ulcere accrue, et procede de production
EP1104673A1 (en) * 1999-11-30 2001-06-06 Bayer Classics A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2010011522A1 (en) * 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CN115697354A (zh) * 2020-06-01 2023-02-03 香港大学 用于治疗sars-cov-2感染的组合物和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (it) * 1988-07-18 1992-03-13 Glaxo Group Ltd
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
CY1988A (en) 1997-09-05
WO1993017679A1 (en) 1993-09-16
US5456925A (en) 1995-10-10
GB9119284D0 (en) 1991-10-23
NL194907C (nl) 2003-07-04
NO920408L (no) 1993-08-02
ITRM910673A0 (it) 1991-09-10
EP0558779A1 (en) 1993-09-08
RU2108097C1 (ru) 1998-04-10
NO179694B (no) 1996-08-26
SE509694C2 (sv) 1999-02-22
SK279591B6 (sk) 1999-01-11
AT405134B (de) 1999-05-25
AU640816B2 (en) 1993-09-02
FI944047A0 (fi) 1994-09-02
NO920408D0 (no) 1992-01-30
RO112084B1 (ro) 1997-05-30
IT1249696B (it) 1995-03-09
CA2050970A1 (en) 1992-03-12
FI944047A (fi) 1994-09-02
ES2072647T3 (es) 1995-07-16
DK159191D0 (da) 1991-09-10
ATA180191A (de) 1998-10-15
DK159191A (da) 1992-03-12
HU211846A9 (en) 1995-12-28
KR100196308B1 (ko) 1999-06-15
NL9101533A (nl) 1992-04-01
SK106094A3 (en) 1995-02-08
ATE122883T1 (de) 1995-06-15
BG99021A (bg) 1995-06-30
GB2248185B (en) 1994-02-02
BG61931B1 (bg) 1998-10-30
OA10093A (en) 1996-12-18
NL194907B (nl) 2003-03-03
SE9102604L (sv) 1992-03-12
GB9019875D0 (en) 1990-10-24
DE4130061A1 (de) 1992-03-12
NO179694C (no) 1996-12-04
JPH0692849A (ja) 1994-04-05
NZ239731A (en) 1993-10-26
ZA917176B (en) 1992-06-24
GB2248185A (en) 1992-04-01
AU8375791A (en) 1992-03-19
CA2050970C (en) 2002-11-19
EP0558779B1 (en) 1995-05-24
BE1005115A5 (fr) 1993-04-27
FR2666508A1 (fr) 1992-03-13
IE913191A1 (en) 1992-04-22
IL99428A (en) 1996-06-18
HK60894A (en) 1994-07-08
SE9102604D0 (sv) 1991-09-10
FR2666508B1 (fr) 1994-02-18
DE69202696D1 (de) 1995-06-29
IE65049B1 (en) 1995-10-04
AU1334792A (en) 1993-10-05
CH683068A5 (fr) 1994-01-14
KR920005984A (ko) 1992-04-27
IL99428A0 (en) 1992-08-18
MX9101009A (es) 1992-05-04

Similar Documents

Publication Publication Date Title
ITRM910673A1 (it) Composizioni farmaceutiche contenenti derivati di furano e procedimento per prepararle.
FI20001231A (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
SE8402549L (sv) Substituerade moranolinderivat
SE8702941L (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
DK403187A (da) Praeparat til transdermal indgift
SE8704952L (sv) Farmaceutisk komposition
IT7927748A0 (it) Derivati dell'acido 6,6'-diapopsi psicarotenedioico e relativi procedimenti di preparazione.
FI913034A0 (fi) Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning.
FI791565A (fi) Farmaceutiska sammansaettningar innehaollande prostaglandinfoereningar
DE3865642D1 (de) Pharmazeutische zubereitung zur cholelitholyse.
IT8648217A0 (it) L-amminoacil derivati della l-carnitina, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' epatoprotettrice che li contengono
NO873385D0 (no) Oksiran-pseudooligosakkarider, fremgangsmaate til deres fremstilling, deres anvendelse og farmasoeytiske preparater.
GB2021581A (en) Stabilisation of PGl2 derivatives
IT7921095A0 (it) Derivati biologicamente attivi della 8 beta-idrazinometil-ergolina eprocedimento per la loro preparazione.
NO894811D0 (no) Vandig doxorubicinloesning.
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
IT8522208A0 (it) Procedimento per la preparazione di derivati furanici con attivita'antiulcera.
SE8704049D0 (sv) Novel pharmacological compounds
IT7830125A0 (it) Associazione di antibiotici caratterizzata da diminuita tossicita', e composizioni farmaceutiche relative.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970929